CellCept, Mycophenolate
CellCept, Mycophenolate Newswire

CellCept, Mycophenolate Newswire

Comprehensive Real-Time News Feed for CellCept, Mycophenolate (generic).

Results 1 - 20 of 42 in CellCept, Mycophenolate (generic)

  1. Mycophenolate triazole Industry 2016 Global and Chinese Market Research ReportRead the original story

    Saturday Jan 30 | Emailwire.com

    WiseGuyReports.com adds 'Global and Chinese Mycophenolate triazole Industry, 2016 Market Research Report' new report to its research database. The report spread across 150 pages with table and figures.

    Comment?

  2. Clinically significant adverse events after major ABO mismatch BMTRead the original story

    Jan 6, 2016 | Bone Marrow Transplantation

    It is well known that RBCs present in a major ABO mismatch bone marrow transplant can cause clinical hemolysis. To prevent this infusion complication, the volume of RBCs in the bone marrow graft can be reduced via various RBC depletion techniques.

    Comment?

  3. Aurinia Announces Completion of Patient Enrollment in Its Phase 2B AURA-LV Study in Lupus NephritisRead the original story

    Tuesday Jan 19 | Business Wire

    This Phase 2B study, is a randomized, controlled, double-blind study comparing the efficacy of voclosporin as a component of multi-targeted therapy against placebo in achieving remission in patients with active lupus nephritis . AURA is one of the largest prospective registration-quality studies ever conducted within this specific disease area.

    Comment?

  4. Systemic Lupus Erythematous SLE Drugs Market: 10-Year Market Forecast ...Read the original story

    Friday Jan 15 | PR.com

    Systemic Lupus Erythematous is a chronic autoimmune disease which causes the immune system to mistakenly attack health body tissue. In SLE, body immune system can affect any part of the body, such as joints, organs, eyes, skin, etc.

    Comment?

  5. Membranoproliferative glomerulonephritis recurrence after kidney...Read the original story

    Sunday Jan 10 | BioMed Central

    Membranoproliferative glomerulonephritis is an uncommon glomerular disorder that may lead to end stage renal disease . With new understanding of the disease pathogenesis, the classical classification as MPGN types I, II, III has changed.

    Comment?

  6. Tubulointerstitial nephritis in primary Sjogren syndrome: clinical...Read the original story

    Jan 4, 2016 | BioMed Central

    Primary SjA gren syndrome is a common autoimmune condition which primarily affects epithelial tissue, often including the kidney causing either tubulointerstitial nephritis or more rarely, an immune complex related glomerulonephritis. We describe the clinical, biochemical and histological characteristics of 12 patients with pSS related TIN and their response to treatment with antiproliferative agents.

    Comment?

  7. Cytomegalovirus infection and disease reduce 10-year cardiac...Read the original story

    Dec 23, 2015 | BioMed Central

    Cytomegalovirus is associated with an increased risk of cardiac allograft vasculopathy , the major limiting factor for long-term survival after heart transplantation . The purpose of this study was to evaluate the impact of CMV infection during long-term follow-up after HTx.

    Comment?

  8. Powder for Oral Suspension 31.8%"Read the original story

    Dec 21, 2015 | PressReleasePoint

    Chugai considered the needs for future transplantation therapy in Japan. We understand that some patients have difficulties in administering the capsule formulation and dosage adjustment.

    Comment?

  9. Low dose of mycophenolate mofetil is enough in desensitized kidney transplantation using rituximabRead the original story

    Dec 4, 2015 | BioMed Central

    Division of Nephrology, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea The electronic version of this article is the complete one and can be found online at:

    Comment?

  10. Neutropenic Enterocolitis: New Insights Into a Deadly Entity.Read the original story

    Nov 29, 2015 | CiteULike

    Neutropenic enterocolitis is a deadly ileocecal-based disease seen in patients with a recent history of chemotherapy. As histology is not included in the current diagnostic criteria, the pathologic features of NE are poorly understood.

    Comment?

  11. Myelin damage of CIDP compromises nervesRead the original story

    Nov 24, 2015 | The Town Talk

    Myelin damage of CIDP compromises nerves Dear Dr. Roach: About eight years ago, I was diagnosed with CIDP . Check out this story on thetowntalk.com: Dear Dr. Roach: About eight years ago, I was diagnosed with CIDP .

    Comment?

  12. Aurinia Announces Outcome From Data And Safety Monitoring Board For...Read the original story

    Nov 23, 2015 | BioSpace

    Aurinia Pharmaceuticals Inc. has announced today that the independent Data and Safety Monitoring Board for the Company's Phase 2b lupus nephritis study, known as AURA-LV, has completed its third pre-planned safety review of patients enrolled in the study and recommended continuation of the trial without any modifications. The AURA-LV DSMB has been established according to the FDA Guidance for Clinical Trial Sponsors and is guided by its charter.

    Comment?

  13. Purinergic receptors in tubulointerstitial inflammatory cells: a...Read the original story

    Nov 17, 2015 | CiteULike

    Recent studies have suggested that both the tubulointerstitial inflammatory cells and the activation of purinergic receptors integrate common mechanisms that result in salt-sensitive hypertension. The basis of this hypothesis is that renal endothelial cells release ATP in response to shear stress in the setting of hypertension.

    Comment?

  14. Batten disease may benefit from gene therapyRead the original story

    Nov 15, 2015 | Holtville Tribune

    In a study of dogs, scientists showed that a new way to deliver replacement genes may be effective at slowing the development of childhood Batten disease, a rare and fatal neurological disorder. The key may be to inject viruses that carry the codes for the gene products into the ventricles, which are fluid-filled compartments in the center of the brain that serve as a plumbing system.

    Comment?

  15. Abstract P012: Mycophenolate Mofetil Prevents Cerebrovascular Injury...Read the original story

    Nov 3, 2015 | Circulation

    The stroke-prone spontaneously hypertensive rat strain develops hypertensive end-organ injury, including strokes and progressive kidney disease, as a result of naturally occurring genetic variations. Our recent work identifies genetic variants in immune signaling pathways that contribute to susceptibility to end organ injury.

    Comment?

  16. New Study Reveals Promising Treatment for Scleroderma-Related Interstitial Lung DiseaseRead the original story

    Nov 7, 2015 | Newswise

    Mycophenolate mofitil is as effective as cyclophosphamide in treating interstitial lung disease in people with scleroderma, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Francisco. Scleroderma, also known as systemic sclerosis, is a chronic inflammatory disease that causes skin thickening and tightening and damage to internal body organs caused by a build-up of scar tissue.

    Comment?

  17. Researchers link organ transplant drug to rise in rare lymphomaRead the original story w/Photo

    Oct 16, 2015 | Medical News Today

    A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil to an increased risk of central nervous system lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors , given alone or in combination with MMF, appears to protect transplant patients against this rare form of lymphoma.

    Comment?

  18. Researchers link organ transplant drug to rise in rare lymphomaRead the original story w/Photo

    Oct 15, 2015 | PhysOrg Weblog

    A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil to an increased risk of central nervous system lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors , given alone or in combination with MMF, appears to protect transplant patients against this rare form of lymphoma.

    Comment?

  19. Link Organ Transplant Drug to Rise in Rare LymphomaRead the original story

    Oct 14, 2015 | Health News Digest

    A study led by Johns Hopkins researchers has linked the immunosuppressive drug mycophenolate mofetil to an increased risk of central nervous system lymphoma in solid organ transplant patients. But the same study also found that another class of immunosuppressive drugs, called calcineurin inhibitors , given alone or in combination with MMF, appears to protect transplant patients against this rare form of lymphoma.

    Comment?

  20. Global Report on Organ Transplant Immunosuppressant Drugs MarketRead the original story w/Photo

    Oct 9, 2015 | SBWire

    This report on the organ transplant immunosuppressant drugs market studies the current and future prospects of the global market. Organ transplant immunosuppressant drugs market are prescribed to patients during or after transplant of organs such as kidney, liver, heart, lung and bone marrow.

    Comment?